AH13205

Modify Date: 2024-01-24 18:10:49

AH13205 structure	Common Name	AH13205
	CAS Number	148436-63-9	Molecular Weight	388.54000
	Density	1.075g/cm3	Boiling Point	574.1ºC at 760mmHg
	Molecular Formula	C₂₄H₃₆O₄	Melting Point	N/A
	MSDS	N/A	Flash Point	315.1ºC

Use of AH13205

AH13205 is an EP2 prostanoid receptor agonist.

Name	trans-2-(4-(1-Hydroxyhexyl)phenyl-5-oxocyclopentaneheptanoic acid
Synonym	More Synonyms

Density	1.075g/cm3
Boiling Point	574.1ºC at 760mmHg
Molecular Formula	C₂₄H₃₆O₄
Molecular Weight	388.54000
Flash Point	315.1ºC
Exact Mass	388.26100
PSA	74.60000
LogP	5.78820
Vapour Pressure	5.06E-14mmHg at 25°C
Index of Refraction	1.528

AH13205 MSDS(Chinese)

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR	NONH for all modes of transport

New reagent system for attaining high regio- and stereoselectivities in allylic displacement of 4-cyclopentene-1,3-diol monoacetate with aryl- and alkenylmagnesium bromides.

Org. Lett. 7(2) , 183-6, (2005)

[Reaction: see text] Low regioselectivity of RMgBr (R = aryl, alkenyl) in the CuCN-catalyzed reaction with 4-cyclopentene-1,3-diol monoacetate is improved by addition of LiCl or MgCl2 to a similar ext...

Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

Molecular Neurodegeneration 5 , 13, (2010)

An early event in the neuropathology of prion and Alzheimer's diseases is the loss of synapses and a corresponding reduction in the level of synaptophysin, a pre-synaptic membrane protein essential fo...

EP4 receptor as a new target for bronchodilator therapy.

Thorax 66(12) , 1029-35, (2011)

Asthma and chronic obstructive pulmonary disease are airway inflammatory diseases characterised by airflow obstruction. Currently approved bronchodilators such as long-acting β(2) adrenoceptor agonist...

7-[(1R,2S)-2-[4-(1-hydroxyhexyl)phenyl]-5-oxocyclopentyl]heptanoic acid